PETAL Consortium Survival Prognosticators and How Inflammation Impacts Hematopoiesis

In this week's episode, Blood associate editor Dr. Laura Michaelis interviews Drs. Mark Sorial and Emmanuelle Passegue on their articles published in volume 147 issue 7 of Blood . Dr. Sorial discusses " Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium " where he and his team evaluated the prognostic significance of early relapse in a large retrospective cohort. They report a time to relapse of <12 months as a strong predictive factor independent of the prognostic index for T-cell lymphoma and histology, with results validated in 2 independent cohorts. Dr. Emmanuelle Passegue discusses " Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche ". Using a combination of single-cell RNA sequencing profiling and flow cytometry, the team characterized the bone marrow niche compartments in mice subjected to inflammation. They show that inter-feron-mediated inflammation preferentially targets central marrow leptin receptor–expressing mesenchymal cells, triggering cytokine release that affects monocyte dynamics in the bone marrow microenvironment.

You can listen to PETAL Consortium Survival Prognosticators and How Inflammation Impacts Hematopoiesis online on Radio and Podcast. Open the player on this page to stream the available audio.

PETAL Consortium Survival Prognosticators and How Inflammation Impacts Hematopoiesis is an episode from Blood Podcast by American Society of Hematology.

This episode is 13:00 long.

This episode was published on Mar 5, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Blood Podcast when more episodes are available from the podcast feed.